These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Pulmonary changes caused by cytostatic drugs]. Akoun G; Milleron B; Mayaud C Ann Med Interne (Paris); 1985; 136(8):671-6. PubMed ID: 3914227 [TBL] [Abstract][Full Text] [Related]
7. [Acute pulmonary complications following intraspinal injection of cytostatic drugs]. Lareng L; Jorda MF; Cathala B Poumon Coeur; 1970; 26(8):961-5. PubMed ID: 5280472 [No Abstract] [Full Text] [Related]
8. [Pulmonary toxicity of antineoplastic agents--with special reference to current findings on pulmonary toxicity of bleomycin]. Okuma K; Ota K Gan To Kagaku Ryoho; 1982 Sep; 9(9):1495-505. PubMed ID: 6191717 [TBL] [Abstract][Full Text] [Related]
9. [Secondary tumors following cytostatic chemotherapy with alkylating agents in man; the toxicological viewpoints]. Schmähl D; Petru E Dtsch Med Wochenschr; 1986 May; 111(21):833-5. PubMed ID: 3698866 [No Abstract] [Full Text] [Related]
10. Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Hahn GM; Shiu EC Cancer Res; 1983 Dec; 43(12 Pt 1):5789-91. PubMed ID: 6196107 [TBL] [Abstract][Full Text] [Related]
11. [A comparison of the destructive effects of five antitumour agents on various normal tissues in mice]. Cheng YS; Li HT; Yang J Yao Xue Xue Bao; 1965 Sep; 12(9):606-14. PubMed ID: 5899044 [No Abstract] [Full Text] [Related]
14. Stage-specific sensitivity of spermatogonia to different chemotherapeutic drugs. Meistrich ML Biomed Pharmacother; 1984; 38(3):137-42. PubMed ID: 6478053 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of toxicity of intravitreal antineoplastic drugs. Peyman GA; Greenberg D; Fishman GA; Fiscella R; Thomas A Ophthalmic Surg; 1984 May; 15(5):411-3. PubMed ID: 6203076 [TBL] [Abstract][Full Text] [Related]
16. Comparison of gene expression changes induced in mouse and human cells treated with direct-acting mutagens. Islaih M; Li B; Kadura IA; Reid-Hubbard JL; Deahl JT; Altizer JL; Watson DE; Newton RK Environ Mol Mutagen; 2004; 44(5):401-19. PubMed ID: 15515172 [TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985. IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383 [No Abstract] [Full Text] [Related]
18. Evaluation of cardiac subacute toxicity of epirubicin, chlorambucil, cisplatin, methotrexate and a homo-aza-steroid ester with antitumor activity in rats using serum biochemical parameters. Pispirigos K; Paradelis AG; Karakiulakis G Arzneimittelforschung; 1997 Jan; 47(1):92-6. PubMed ID: 9037452 [TBL] [Abstract][Full Text] [Related]
19. Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis? Pitini V; Arrigo C; Altavilla G; Naro C Leuk Res; 2007 Jul; 31(7):1027-8. PubMed ID: 17134751 [No Abstract] [Full Text] [Related]
20. [Respiratory failure and pulmonary fibrosis as a late side-effect after chemotherapy-induced by oxygen administration]. Grahmann PR; Brauer M; Hüter L; Sayer H; Neumann R; Braun RK Pneumologie; 2005 Nov; 59(11):763-9. PubMed ID: 16385437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]